Hepatitis Monthly

Published by: Kowsar

HCV dsRNA-Activated Macrophages Inhibit HCV Replication in Hepatocytes

Yizhong Wang 1 , Jieliang Li 2 , Xu Wang 2 , Yu Zhou 2 , Ting Zhang 1 , * and Wenzhe Ho 2 , *
Authors Information
1 Department of Infectious Diseases, Shanghai Children’s Hospital, Shanghai Jiao Tong University, Shanghai, China
2 Department of Pathology and Laboratory Medicine, School of Medicine, Temple University, Philadelphia, USA
Corresponding Authors:
Article information
  • Hepatitis Monthly: August 2015, 15 (8); e29282
  • Published Online: August 30, 2015
  • Article Type: Research Article
  • Received: April 15, 2015
  • Revised: June 17, 2015
  • Accepted: July 26, 2015
  • DOI: 10.5812/hepatmon.29282

To Cite: Wang Y, Li J, Wang X, Zhou Y, Zhang T, et al. HCV dsRNA-Activated Macrophages Inhibit HCV Replication in Hepatocytes, Hepat Mon. 2015 ;15(8):e29282. doi: 10.5812/hepatmon.29282.

Copyright: Copyright © 2015, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Alter MJ. Prevention of spread of hepatitis C. Hepatology. 2002; 36(5 Suppl 1)-8[DOI][PubMed]
  • 2. Kawai T, Akira S. Toll-like receptor and RIG-I-like receptor signaling. Ann N Y Acad Sci. 2008; 1143: 1-20[DOI][PubMed]
  • 3. Kawai T, Akira S. Innate immune recognition of viral infection. Nat Immunol. 2006; 7(2): 131-7[DOI][PubMed]
  • 4. Kumar A, Zhang J, Yu FS. Toll-like receptor 3 agonist poly(I:C)-induced antiviral response in human corneal epithelial cells. Immunology. 2006; 117(1): 11-21[DOI][PubMed]
  • 5. West J, Damania B. Upregulation of the TLR3 pathway by Kaposi's sarcoma-associated herpesvirus during primary infection. J Virol. 2008; 82(11): 5440-9[DOI][PubMed]
  • 6. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature. 2001; 413(6857): 732-8[DOI][PubMed]
  • 7. Wang N, Liang Y, Devaraj S, Wang J, Lemon SM, Li K. Toll-like receptor 3 mediates establishment of an antiviral state against hepatitis C virus in hepatoma cells. J Virol. 2009; 83(19): 9824-34[DOI][PubMed]
  • 8. Janeway CAJ, Medzhitov R. Innate immune recognition. Annu Rev Immunol. 2002; 20: 197-216[DOI][PubMed]
  • 9. Li J, Ye L, Wang X, Hu S, Ho W. Induction of interferon-gamma contributes to Toll-like receptor 3-mediated herpes simplex virus type 1 inhibition in astrocytes. J Neurosci Res. 2012; 90(2): 399-406[DOI][PubMed]
  • 10. Zhou Y, Wang X, Liu M, Hu Q, Song L, Ye L, et al. A critical function of toll-like receptor-3 in the induction of anti-human immunodeficiency virus activities in macrophages. Immunology. 2010; 131(1): 40-9[DOI][PubMed]
  • 11. Battaglia AM, Hagmeyer KO. Combination therapy with interferon and ribavirin in the treatment of chronic hepatitis C infection. Ann Pharmacother. 2000; 34(4): 487-94[PubMed]
  • 12. Gale MJ, Foy EM. Evasion of intracellular host defence by hepatitis C virus. Nature. 2005; 436(7053): 939-45[DOI][PubMed]
  • 13. Li K, Foy E, Ferreon JC, Nakamura M, Ferreon AC, Ikeda M, et al. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci U S A. 2005; 102(8): 2992-7[DOI][PubMed]
  • 14. Foy E, Li K, Sumpter RJ, Loo YM, Johnson CL, Wang C, et al. Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. Proc Natl Acad Sci U S A. 2005; 102(8): 2986-91[DOI][PubMed]
  • 15. Li XD, Sun L, Seth RB, Pineda G, Chen ZJ. Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc Natl Acad Sci U S A. 2005; 102(49): 17717-22[DOI][PubMed]
  • 16. Racanelli V, Rehermann B. The liver as an immunological organ. Hepatology. 2006; 43(2 Suppl 1)-62[DOI][PubMed]
  • 17. Khakoo SI, Soni PN, Savage K, Brown D, Dhillon AP, Poulter LW, et al. Lymphocyte and macrophage phenotypes in chronic hepatitis C infection. Correlation with disease activity. Am J Pathol. 1997; 150(3): 963-70[PubMed]
  • 18. Heydtmann M. Macrophages in hepatitis B and hepatitis C virus infections. J Virol. 2009; 83(7): 2796-802[DOI][PubMed]
  • 19. Hassan NF, Campbell DE, Douglas SD. Purification of human monocytes on gelatin-coated surfaces. J Immunol Methods. 1986; 95(2): 273-6[PubMed]
  • 20. Li K, Li NL, Wei D, Pfeffer SR, Fan M, Pfeffer LM. Activation of chemokine and inflammatory cytokine response in hepatitis C virus-infected hepatocytes depends on Toll-like receptor 3 sensing of hepatitis C virus double-stranded RNA intermediates. Hepatology. 2012; 55(3): 666-75[DOI][PubMed]
  • 21. Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, Burton DR, et al. Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci U S A. 2005; 102(26): 9294-9[DOI][PubMed]
  • 22. Yang JH, Lai JP, Douglas SD, Metzger D, Zhu XH, Ho WZ. Real-time RT-PCR for quantitation of hepatitis C virus RNA. J Virol Methods. 2002; 102(1-2): 119-28[PubMed]
  • 23. Katze MG, He Y, Gale MJ. Viruses and interferon: a fight for supremacy. Nat Rev Immunol. 2002; 2(9): 675-87[DOI][PubMed]
  • 24. Tuplin A, Wood J, Evans DJ, Patel AH, Simmonds P. Thermodynamic and phylogenetic prediction of RNA secondary structures in the coding region of hepatitis C virus. RNA. 2002; 8(6): 824-41[PubMed]
  • 25. Liu X, He N, Fu Z, Duan S, Gao M, Zhang ZF. Plasma Hepatitis C Virus Viral Load Among Hepatitis C Virus Mono-Infected and HCV/HIV Co-Infected Individuals in Yunnan Province,China. Hepat Mon. 2012; 12(7): 453-9[DOI][PubMed]
  • 26. Zhang S, Kodys K, Li K, Szabo G. Human type 2 myeloid dendritic cells produce interferon-lambda and amplify interferon-alpha in response to hepatitis C virus infection. Gastroenterology. 2013; 144(2): 414-425 e7[DOI][PubMed]
  • 27. Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol. 2005; 17(1): 1-14[DOI][PubMed]
  • 28. Argentini C, Genovese D, Dettori S, Rapicetta M. HCV genetic variability: from quasispecies evolution to genotype classification. Future Microbiol. 2009; 4(3): 359-73[DOI][PubMed]
  • 29. Radkowski M, Bednarska A, Horban A, Stanczak J, Wilkinson J, Adair DM, et al. Infection of primary human macrophages with hepatitis C virus in vitro: induction of tumour necrosis factor-alpha and interleukin 8. J Gen Virol. 2004; 85: 47-59[PubMed]
  • 30. Revie D, Salahuddin SZ. Role of macrophages and monocytes in hepatitis C virus infections. World J Gastroenterol. 2014; 20(11): 2777-84[DOI][PubMed]
  • 31. Fletcher NF, Sutaria R, Jo J, Barnes A, Blahova M, Meredith LW, et al. Activated macrophages promote hepatitis C virus entry in a tumor necrosis factor-dependent manner. Hepatology. 2014; 59(4): 1320-30[DOI][PubMed]
  • 32. Negash AA, Ramos HJ, Crochet N, Lau DT, Doehle B, Papic N, et al. IL-1beta production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease. PLoS Pathog. 2013; 9(4)[DOI][PubMed]
  • 33. Canbay A, Feldstein AE, Higuchi H, Werneburg N, Grambihler A, Bronk SF, et al. Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression. Hepatology. 2003; 38(5): 1188-98[DOI][PubMed]
  • 34. Dolganiuc A, Oak S, Kodys K, Golenbock DT, Finberg RW, Kurt-Jones E, et al. Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation. Gastroenterology. 2004; 127(5): 1513-24[PubMed]
  • 35. Chang S, Dolganiuc A, Szabo G. Toll-like receptors 1 and 6 are involved in TLR2-mediated macrophage activation by hepatitis C virus core and NS3 proteins. J Leukoc Biol. 2007; 82(3): 479-87[DOI][PubMed]
  • 36. Chattergoon MA, Latanich R, Quinn J, Winter ME, Buckheit R3, Blankson JN, et al. HIV and HCV activate the inflammasome in monocytes and macrophages via endosomal Toll-like receptors without induction of type 1 interferon. PLoS Pathog. 2014; 10(5)[DOI][PubMed]
  • 37. Alavian SM, Ande SR, Coombs KM, Yeganeh B, Davoodpour P, Hashemi M, et al. Virus-triggered autophagy in viral hepatitis - possible novel strategies for drug development. J Viral Hepat. 2011; 18(12): 821-30[DOI][PubMed]
  • 38. Khattab MA, Eslam M, Alavian SM. Hepatitis C virus as a multifaceted disease: a simple and updated approach for extrahepatic manifestations of hepatitis C virus infection. Hepat Mon. 2010; 10(4): 258-69[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader